Covid-19 Vaccine from Pfizer and BioNTech Shows Positive Results
By News
Published 4 years ago on
July 1, 2020
Share
[aggregation-styles]
Stat News
An experimental Covid-19 vaccine being developed by the drug giant Pfizer and the biotech firm BioNTech spurred immune responses in healthy patients, but also caused fever and other side effects not deemed serious.
The first clinical data on the vaccine were disclosed Wednesday in a paper released on medRXiv, a preprint server, meaning it has not yet been peer-reviewed or published in a journal.
“We still have a ways to go and we’re testing other candidates as well,” said Philip Dormitzer, the chief scientific officer for viral vaccines at Pfizer’s research laboratories. “However, what we can say at this point is there is a viable candidate based on immunogenicity and early tolerability safety data.”
The study showed that the vaccine generated antibodies against SARS-CoV-2, the virus that causes Covid-19, and some of these antibodies were neutralizing, meaning that they appear to prevent the virus from functioning.
Fourteen Covid-19 vaccines are currently in human trials, according to the Milken Institute, including entrants from Inovio, CanSino, AstraZeneca, and Moderna. More are expected to start soon, including entrants from Merck, Johnson & Johnson, and Sanofi. In total, 178 vaccines are in various stages of development.
Read More →
Stat News
An experimental Covid-19 vaccine being developed by the drug giant Pfizer and the biotech firm BioNTech spurred immune responses in healthy patients, but also caused fever and other side effects not deemed serious.
The first clinical data on the vaccine were disclosed Wednesday in a paper released on medRXiv, a preprint server, meaning it has not yet been peer-reviewed or published in a journal.
“We still have a ways to go and we’re testing other candidates as well,” said Philip Dormitzer, the chief scientific officer for viral vaccines at Pfizer’s research laboratories. “However, what we can say at this point is there is a viable candidate based on immunogenicity and early tolerability safety data.”
The study showed that the vaccine generated antibodies against SARS-CoV-2, the virus that causes Covid-19, and some of these antibodies were neutralizing, meaning that they appear to prevent the virus from functioning.
Fourteen Covid-19 vaccines are currently in human trials, according to the Milken Institute, including entrants from Inovio, CanSino, AstraZeneca, and Moderna. More are expected to start soon, including entrants from Merck, Johnson & Johnson, and Sanofi. In total, 178 vaccines are in various stages of development.
Read More →
By Matthew Herper | 1 July 2020
RELATED TOPICS:
No data was found
Facebook News Tab Will Soon Be Unavailable as Meta Scales Back News and Political Content
Tech /
15 hours ago
Stock Market Today: Wall Street Rises to More Records to Close Out Its Latest Winning Month
Economy /
15 hours ago
A Fresno County First: Kerman Council Passes Amended Gaza Cease-Fire Resolution
Politics /
15 hours ago
UN Top Court Orders Israel to Open More Land Crossings for Aid into Gaza
World /
16 hours ago
Ex-Correctional Officer at Women’s Prison in California Sentenced for Sexually Abusing Inmates
Crime /
20 hours ago
Caitlin Clark and Iowa Draw Nearly 5 Million Viewers for Second-Round NCAA Win
Sports /
20 hours ago
Latest
Videos
Sports /
15 hours ago
Cronenworth’s Big Hit Helps Lift the Padres to a 6-4 Win Over Melvin’s Giants
Sports /
15 hours ago
Shohei Ohtani Reaches 3 Times in Home Debut as the Dodgers Rout the Cardinals 7-1
Tech /
15 hours ago
Facebook News Tab Will Soon Be Unavailable as Meta Scales Back News and Political Content
Economy /
15 hours ago
Stock Market Today: Wall Street Rises to More Records to Close Out Its Latest Winning Month
Politics /
15 hours ago
A Fresno County First: Kerman Council Passes Amended Gaza Cease-Fire Resolution
World /
16 hours ago